SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-21-103746
Filing Date
2021-08-12
Accepted
2021-08-12 07:13:13
Documents
1
Group Members
IRA SCOTT GREENSPANJOSHUA R. LAMSTEIN

Document Format Files

Seq Description Document Type Size
1 SC 13D tm2124811d2_sc13d.htm SC 13D 73202
  Complete submission text file 0001104659-21-103746.txt   74874
Mailing Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170 (212) 479-2513
Scopus BioPharma Inc. (Subject) CIK: 0001772028 (see all company filings)

IRS No.: 821248020 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92033 | Film No.: 211165487
SIC: 2834 Pharmaceutical Preparations

Mailing Address 420 LEXINGTON AVENUE SUITE 300 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 300 NEW YORK NY 10170 (917) 674-3889
HCFP/Capital Partners 18B-2 LLC (Filed by) CIK: 0001875687 (see all company filings)

IRS No.: 371881518 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D